title: Continuous 24-h monitoring of electrocardiogram during anthracycline-based therapy in acute leukemia.
authors.forename: M
authors.initials: M
authors.lastname: Jakl
authors.forename: J M
authors.initials: JM
authors.lastname: Horacek
authors.forename: L
authors.initials: L
authors.lastname: Jebavy
authors.forename: R
authors.initials: R
authors.lastname: Pudil
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects*; D054715:Cardiotoxins / Q000008:administration & dosage*; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D004562:Electrocardiography; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced / Q000503:physiopathology*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects; D008991:Monitoring, Physiologic / Q000379:methods*
chemical_list: D054715:Cardiotoxins; D003561:Cytarabine; D008942:Mitoxantrone; D003630:Daunorubicin